Wormwood Moser Kelly L, Van Aken Gregory, DeBord Daniel, Hatcher Nathan Galen, Maxon Laura, Sherman Melissa, Yao Lihang, Ekroos Kim
MOBILion Systems, Inc., Chadds Ford, PA, USA.
Merck & Co., Inc., Kenilworth, NJ, USA.
Anal Chim Acta. 2021 Feb 15;1146:77-87. doi: 10.1016/j.aca.2020.12.022. Epub 2020 Dec 16.
Defects in sphingolipid metabolism have emerged as a common link across neurodegenerative disorders, and a deeper understanding of the lipid content in preclinical models and patient specimens offers opportunities for development of new therapeutic targets and biomarkers. Sphingolipid metabolic pathways include the formation of glycosphingolipid species that branch into staggeringly complex structural heterogeneity within the globoside and ganglioside sub-lipidomes. Characterization of these sub-lipidomes has typically relied on liquid chromatography-mass spectrometry-based (LC-MS) approaches, but such assays are challenging and resource intensive due to the close structural heterogeneity, the presence of isobaric and isomeric species, and broad dynamic range of endogenous glycosphingolipids. Here, we apply Structures for Lossless Ion Manipulations (SLIM)-based High Resolution Ion Mobility (HRIM)-MS to enable rapid, repeatable, quantitative assays with deep structural information sufficient to resolve endogenous brain gangliosides at the level of individual molecular species. Analyses were performed using a prototype SLIM-MS instrument equipped with a 13-m serpentine path which enabled resolution of closely related isomeric analytes such as GD1a d36:1 and GD1b d36:1 based on recorded mass-to-charge (m/z) and arrival times. To demonstrate the power of our methodology, brain extracts derived from wild-type mice hemi-brains were analyzed by HRIM-MS using flow injection analyses (FIA) without the need for additional separation by liquid chromatography. Endogenous ganglioside species were readily resolved, identified, and quantified by FIA-SLIM-MS analyses within 2 min per sample. Thus, the FIA-SLIM-MS platform enables robust quantification across a broad range of lipid species in biological specimens in a standardized assay format that is readily scalable to support studies with large sample numbers.
鞘脂代谢缺陷已成为神经退行性疾病的一个共同关联因素,对临床前模型和患者标本中脂质含量的更深入了解为开发新的治疗靶点和生物标志物提供了机会。鞘脂代谢途径包括糖鞘脂种类的形成,这些糖鞘脂种类在球苷脂和神经节苷脂亚脂质组内分支成惊人复杂的结构异质性。这些亚脂质组的表征通常依赖于基于液相色谱 - 质谱(LC-MS)的方法,但由于结构异质性接近、存在等压和同分异构体种类以及内源性糖鞘脂的宽动态范围,此类分析具有挑战性且资源密集。在这里,我们应用基于无损离子操纵结构(SLIM)的高分辨率离子淌度(HRIM)-MS,以实现快速、可重复的定量分析,并提供足以在单个分子种类水平解析内源性脑神经节苷脂的深度结构信息。使用配备13米蛇形路径且基于记录的质荷比(m/z)和到达时间能够分辨密切相关的同分异构体分析物(如GD1a d36:1和GD1b d36:1)的原型SLIM-MS仪器进行分析。为了证明我们方法的强大功能,使用流动注射分析(FIA)通过HRIM-MS对源自野生型小鼠半脑的脑提取物进行分析,无需通过液相色谱进行额外分离。通过FIA-SLIM-MS分析,每个样品在2分钟内即可轻松分辨、鉴定和定量内源性神经节苷脂种类。因此,FIA-SLIM-MS平台能够以标准化的分析形式对生物标本中的广泛脂质种类进行可靠定量,该形式易于扩展以支持大量样本的研究。